5. Rheumatoid arthritis Flashcards

1
Q

Do arthritis patients present with pain in their back?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Does rheumatoid arthritis affect one or both hands?

A

Symmetrical - always affects both (same with wrists, knee etc.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When is stiffness around the joins particularly bad during the day?

A

In the morning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What usually helps stiffness in the joints

A

Exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the key features of RA?

A
  • Chronic arthritis - symmetrical polyarthritis, untreated - destruction
  • Extra-articular disease can occur e.g. rheumatoid nodules, vasculitis (rare) due to rheumatoid factor
  • Rheumatoid factor may be detected in blood - IgM autoantibody against IgG that can form immune complexes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Is RA more common in males or females?

A

Females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the genetic component of the pathogenesis of RA

A
  • Specific set of amino acids within the beta chain of the DR molecule
  • It is conserved among all HLA subtypes associated with RA
  • Suggests that this is the antigen binding group (HLA-DR antigen binding groove) associated with RA
  • Referred to as the shared epitope
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is smoking related to RA?

A
  • Affects the susceptibility and severity of the disease - smokers with RA are generally far worse than non-smokers
  • Interacts with the shared epitope to increase risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the most commonly affected joints in RA?

A
  • Metacarpophalangeal joint (MCP)
  • Proximal interphalangeal joint (PIP)
  • Wrists
  • Knees
  • Ankles
  • Metatarsophalangeal joint (MTP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What type of change will untreated and chronic RA result in?

A
  • Mechanical change

* e.g. change in shape can cause callous formation under the heads of metatarsals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is Swan-neck deformity?

A

Hyperflexion at the DIP and hyperextension at the PIP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Boutonniere deformity?

A

Hyperflexion at the PIP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a whole swollen digit referred to as?

A

Dactylitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Can several fully swollen fingers be explained by RA?

A

No (as in this case it’s not just the joint affected)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What wraps around the tendons to allow them to move freely?

A

Tenosynovium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can you confirm that synovitis is around the tendons and not the joints e.g. extensor tenosynovitis?

A
  • Ask the patient to raise their fingers

* You will see the swelling being pulled back

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are bursars and what happens when they are inflamed?

A
  • Pockets of fluid on the surface of the joints

* Inflammation => bursitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How are rheumatoid nodules formed?

A

• Rheumatoid factor produces immune complexes that can deposit in any tissue
- IgM binds to Fc portion of IgG
• Tendency to deposit in subcutaneous tissue (and cause extra-articular manifestations - rare)
• Effects are outside the synovium
• Associated with severe disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Where are rheumatoid nodules commonly seen?

A

Along the ulnar border of the forearm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Is the patient always ‘rheumatoid factor positive’ if rheumatoid nodules are present?

21
Q

Can the test for rheumatoid factor be diagnostic for RA and why?

A

No, as 1/3 of RA is rheumatoid factor negative

22
Q

How specific are antibodies against citrullinated peptides in RA?

A

Highly specific - anti-cyclic citrullinated peptide antibody (Anti-CCP)

23
Q

What is ‘citrullination’ and which enzymes mediate it?

A

Post-translational modification of arginine by peptidyl arginine deaminases (PADs)

24
Q

Why do citrullinated peptide antigens develop in rheumatoid arthritis?

A
  • PADs are present in high conc. in neutrophils and monocytes
  • Increased citrullination of autologous peptides in the inflamed synovium
  • Strongly associated with smoking and the HLA ‘shared epitope’
  • Citrulline binds much better than arginine to the specific peptide sequence conserved in the MHC (that is associated with RA)
  • The shared epitope preferentially binds non-polar amino acids such as citrulline
25
Q

What are common (and uncommon) extra-articular features of RA?

A

Common
• Fever
• Weight loss
• Subcutaneous nodules

(Uncommon
• Vasculitis
• Neuropathies
• Amyloidosis
• Lung disease)
26
Q

Why is a citrullinated antigen more likely to elicit an auto-immune response?

A
  • Binds better to the HLA-DR peptide groove (amino acids 70-74 of the HLA-DRβ chain)
  • More likely to present to T cells
  • More like to get auto-immunity
27
Q

Why are multiple different HLA serotypes associated with RA e.g. HLA-DR4, -DR1, -DR6, -DR10

A
  • They all contain the shared epitope (amino acids 70-74 of the HLA-DRβ chain)
  • Some individuals with HLA-DR4 not at risk (as some don’t contain the shared epitope)
28
Q

What are the early and later radiographic abnormalities seen in RA?

A
  • Early - juxta-articular osteopenia

* Later - joint erosions at margins of the joint, deformity and destruction

29
Q

What happens to the synovial membrane in RA?

A

Thickened and chronically inflamed (pannus)

30
Q

What is the ‘bare area’ in RA?

A
  • Where erosion if first seen on the bone
  • Pannus normally destroys the cartilage before it reaches the bone
  • Peri-articular erosions are seen first
31
Q

How thick is the synovium?

A

Single cell lining

32
Q

Which cells produce synovial fluid from within the synovial lining?

A
  • Macrophages and fibroblasts

* Within the synovial lining

33
Q

What is the consistency of the synovial fluid and why?

A
  • Viscous

* Lot of hyaluronic acid

34
Q

What is the articular cartilage made up of?

A

Type 2 collagen (contains a proteoglycan)

35
Q

What is the main proteoglycan in articular cartilage?

36
Q

What is the synovium made up of?

A
  • Type 1 collagen (fibroblast-like, produce hyaluronic acid)

* Macrophage-like cells (clear debris within the joints)

37
Q

What structural and cellular changes cause the inflammation of the synovium (pannus)?

A
  • Neovascularisation
  • Lymphangiogenesis - formation of new lymphatic vessels
  • Inflammatory cells activated: B cells, T cells, plasma cells, mast cells, macrophages
38
Q

Outline the cytokine imbalance in RA?

A
  • Excess of pro-inflammatory cytokines
  • IL-1, IL-6 and TNF-α mainly involved
  • TNF-α is the dominant pro-inflammatory cytokine in the synovium
  • It’s pleiotropic actions (multiple effects from single gene) are detrimental
39
Q

Why is TNF-α so significant in the cytokine imbalance and how is this useful in treatment?

A
  • Top of hierarchy in the cytokine system
  • If you down-regulate TNF-α, you down-regulate lots of other pro-inflammatory cytokines
  • TNF-α inhibition has excellent therapeutic effects
  • Administered through parenteral administration (mainly subcutaneous) of antibodies and fusion proteins
40
Q

How is TNF-α mainly produced (affecting RA)?

A

By activated macrophages in the rheumatoid synovium

41
Q

What is the treatment goal in RA?

A
  • Prevent joint damage
  • Multi-disciplinary approach involving physiotherapists, surgery etc.
  • Pharmaceutical interventions are necessary
  • Treat natural history of the disease, pain and inflammation
42
Q

What do Disease-Modifying Anti-Rheumatic Drugs (DMARDs) do?

A

• Drugs that control the disease process
• Started early (as joint damage = inflammation x time)
• ‘Steroid-sparing agents’
• Safer and more effective long-term treatment than steroids
• Do not cure RA - they may induce remission and prevent joint damage
e.g. methotrexate

43
Q

When is glucocorticoid therapy useful for RA?

A
  • Useful for short-term use e.g. control an exacerbation of the disease or inflammation of a single joint
  • Preferred to avoid long-term use due to side effects
44
Q

How fast is the onset of action for DMARDs?

A

Slow i.e. weeks

45
Q

How are patients monitored whilst on DMARDs and why?

A
  • Regular blood tests
  • Significant adverse effects
  • Look at LFTs every 6-8 weeks
  • Changes in the tests are seen way before people fell unwell
46
Q

What biological therapy interventions can help RA?

A
  • Anti TNF-α - infliximab, fusion protein
  • B cell depletion - rituximab
  • Modulation of T cell co-stimulation
  • Inhibition of IL-6
47
Q

How are newer biological therapies for RA different to older therapies?

A
  • Older - mouse antibodies (chimeric) => could trigger a human anti-chimeric response
  • Newer - completely human antibodies => no chimeric antibody response
48
Q

What are the disadvantages of biological therapy?

A
  • Expensive
  • Increased infection risk (side effect)
  • TNF-α is important in granuloma formation e.g. important in TB, so blocking it could cause death from disseminated TB
  • TNF-α inhibition is associated with increased susceptibility to mycobacterial infection
  • B cell depletion can be associated with hepatitis B reactivation, JC virus infection and progressive multifocal leukoencephalopathy (PML)